|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 254.60 GBX | +4.17% |
|
+1.92% | -10.29% |
| 09:51am | Waldencast Says US FDA Approves Obagi Saypha ChIQ Injectable Hyaluronic Acid Gel | MT |
| Jun. 11 | Spire Healthcare takeover deadline for Toscafund extended to June 25 | RE |
| Market Cap | 2.15B 2.88B 2.49B 2.29B 4.03B 273B 4.07B 27.04B 10.56B 133B 10.82B 10.59B 462B | P/E Ratio 2026 * |
10.8x | P/E Ratio 2027 * | 9.23x |
|---|---|---|---|---|---|
| Enterprise Value | 2.54B 3.42B 2.95B 2.71B 4.78B 323B 4.83B 32.06B 12.52B 158B 12.83B 12.56B 547B | EV / Sales 2026 * |
3.94x | EV / Sales 2027 * | 3.42x |
| Free-Float |
80.01% | Yield 2026 * |
4.11% | Yield 2027 * | 4.35% |
Last Transcript: Bridgepoint Group plc
| Apr. 14 | Morgan Stanley cuts Berkeley and Barratt Redrow | AN |
| Mar. 13 | RBC raises Admiral; UBS ups Rentokil Initial | AN |
| Dec. 15 | Jefferies cuts Tesco, AB Foods and Next | AN |
| Dec. 09 | Deutsche Bank Research raises Relx to 'buy' | AN |
| Nov. 24 | Cavendish Begins Bridgepoint Group's Coverage at Buy | MT |
| 1 day | +4.58% | ||
| 1 week | +1.92% | ||
| Current month | -5.70% | ||
| 1 month | -4.43% | ||
| 3 months | +6.08% | ||
| 6 months | -8.48% | ||
| Current year | -10.29% |
| 1 week | 237.6 |  | 258.4 |
| 1 month | 237.4 | | 279.2 |
| Current year | 212 | | 297.2 |
| 1 year | 212 | | 366.68 |
| 3 years | 164.8 | | 410 |
| 5 years | 164.8 | | 571 |
| 10 years | 164.8 | | 571 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Hughes
CEO | Chief Executive Officer | 61 | 2023-09-30 |
Ruth Prior
DFI | Director of Finance/CFO | 59 | 2024-12-31 |
Jamie Lucas
COO | Chief Operating Officer | 37 | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan Hughes
BRD | Director/Board Member | 61 | 2023-09-30 |
Archibald Norman
BRD | Director/Board Member | 72 | 2021-06-24 |
Carolyn McCall
BRD | Director/Board Member | 65 | 2021-07-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Mar. 31 | Free | Chief Financial Officer | 276,095 | 0.0314% | ||
| Mar. 31 | Free | Chief Executive Officer | 375,489 | 0.0428% | ||
| Mar. 31 | Free | Chief Executive Officer | 270,352 | 0.0308% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.17% | +1.92% | -9.91% | +17.11% | 2.88B | |
| +0.87% | -1.39% | +5.38% | +30.45% | 35.53B | |
| +2.38% | +0.51% | -29.58% | -19.48% | 22.61B | |
| +2.39% | +3.67% | -15.92% | - | 15.76B | |
| +0.30% | +2.69% | +5.30% | +56.08% | 6.04B | |
| -1.22% | -0.41% | -14.34% | +7.68% | 1.2B | |
| +0.63% | +11.11% | -0.62% | - | 950M | |
| -0.52% | -2.31% | +18.80% | +64.66% | 795M | |
| +0.89% | +0.64% | +26.55% | +52.54% | 766M | |
| +0.01% | +0.37% | +5.56% | -5.71% | 738M | |
| Average | +1.00% | +0.66% | -0.88% | +25.42% | 8.73B | |
| Weighted average by Cap. | +1.66% | -1.01% | -8.06% | +15.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 646M 869M 749M 689M 1.21B 82.08B 1.23B 8.14B 3.18B 40.2B 3.26B 3.19B 139B | 725M 975M 840M 773M 1.36B 92.13B 1.38B 9.14B 3.57B 45.12B 3.66B 3.58B 156B |
| Net income | 233M 314M 270M 249M 438M 29.63B 443M 2.94B 1.15B 14.51B 1.18B 1.15B 50.22B | 281M 378M 326M 300M 528M 35.7B 533M 3.54B 1.38B 17.48B 1.42B 1.39B 60.49B |
| Net Debt | 398M 535M 461M 424M 747M 50.54B 755M 5.01B 1.96B 24.75B 2.01B 1.96B 85.64B | 333M 447M 385M 355M 625M 42.26B 631M 4.19B 1.64B 20.69B 1.68B 1.64B 71.61B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-15 | 254.60 p | +4.17% | 1,174,174 |
| 26-06-12 | 244.40 p | +2.35% | 803,389 |
| 26-06-11 | 238.80 p | -2.29% | 3,546,294 |
| 26-06-10 | 244.40 p | -0.33% | 3,593,791 |
| 26-06-09 | 245.20 p | -1.37% | 2,984,586 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BPT Stock
Select your edition
All financial news and data tailored to specific country editions
